Over the last six years we’ve been lucky enough to work with a range of innovative and exciting entrepreneurs – but none have had a product comparable to the biotech start-up Cydar.
Spun out of Kings College, its technology is already helping surgeons by radically improving the quality of images they use while performing delicate keyhole surgery. The easiest way to think of Cydar is that it’s a ‘sat nav for surgeons’.
The idea emerged from operating theatres where Cydar co-founder and vascular surgeon Tom Carrell was consistently frustrated by the poor imaging technology he had at his disposal. The need for repeated x-rays was not only expensive – it also posed medical risks for both patients and medical staff.
In fact the name Cydar came from Tom having to repeatedly ask his surgical team ‘Can You Do Another Resolution’?
Already cleared for use within the EU, Cydar wanted an immediate piece of top tier coverage for the news that it’d received clearance from the US Food and Drugs Administration – the key message was that Cydar is now able to market its technology on both sides of the Atlantic.
We responded by placing a great feature in Forbes – perfect coverage for a rapidly growing start-up, keen to catch the eye of future investors.
And with several significant developments in the pipeline, keep an eye out for more news from the ‘sat nav for surgeons’.
